Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune Fortifying RNAs (UNIFYRs™) as a new class of RNA therapeutics poised to transform cancer treatment. GAINESVILLE, Fla., Oct. 19, 2025 /PRNewswire/ -- iOncologi, Inc., a...
Hence then, the article about ioncologi secures foundational u s patent as landmark studies link covid19 mrna vaccines to improved survival with cancer immunotherapy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy )
Also on site :
- Pedestrian killed on 101 Freeway in Calabasas-Agoura Hills area
- Certis and FieldAI Form Strategic Partnership to Deploy Autonomous Robotics in Real-World Security Operations
- AI agents that do your work while you sleep sound great. The reality is far messier—‘it’s like a toddler that needs to be overseen’